The association between parental SARS-CoV-2 infection in pregnancy and fetal growth restriction
© 2023 Walter de Gruyter GmbH, Berlin/Boston..
OBJECTIVES: Although the relationship between maternal viral infections and fetal growth restriction (FGR) is well established, the association between SARS-CoV-2 infection in pregnancy and FGR remains unclear. We investigated the association between SARS-CoV-2 infection in pregnancy and FGR at a single county hospital.
METHODS: We performed a prospective cohort study with cohorts matched by gestational age and month of SARS-CoV-2 PCR testing between April 2020 and July 2022. Individuals were included if they had a SARS-CoV-2 PCR testing up to 32 weeks of gestation and had a third trimester ultrasound. Primary outcome was a diagnosis of FGR, while secondary outcomes were rates of preeclampsia, small for gestational age (SGA) and birthweight. Univariate analyses, chi-square test and logistic regression were used for analysis.
RESULTS: Our cohorts constituted of 102 pregnant individuals with a positive SARS-CoV-2 PCR test result and 103 pregnant individuals with a negative SARS-CoV-2 PCR test result in pregnancy. FGR rates were 17.8 % and 19.42 % among positive and negative SARS-CoV-2 cohorts respectively. While a statistical difference in preeclampsia rates was noted (34.31 % vs. 21.36 %, p=0.038) between cohorts, odds of getting preeclampsia based on SARS-CoV-2 test result was not significant (aOR 1.01, CI=0.97-1.01, p=0.75). No statistical difference was noted in demographics, FGR and SGA rates, and birthweight.
CONCLUSIONS: Our findings suggest no association between SARS-CoV-2 infection in pregnancy and FGR at a single institution. Our results validate emerging data that additional fetal growth ultrasonographic assessment is not indicated solely based on SARS-CoV-2 infection status.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:52 |
---|---|
Enthalten in: |
Journal of perinatal medicine - 52(2024), 3 vom: 25. März, Seite 317-321 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Mitta, Melanie [VerfasserIn] |
---|
Links: |
---|
Themen: |
Birthweight |
---|
Anmerkungen: |
Date Completed 07.03.2024 Date Revised 07.03.2024 published: Electronic-Print Citation Status MEDLINE |
---|
doi: |
10.1515/jpm-2023-0406 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM366509705 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM366509705 | ||
003 | DE-627 | ||
005 | 20240307232148.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240108s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1515/jpm-2023-0406 |2 doi | |
028 | 5 | 2 | |a pubmed24n1319.xml |
035 | |a (DE-627)NLM366509705 | ||
035 | |a (NLM)38160330 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Mitta, Melanie |e verfasserin |4 aut | |
245 | 1 | 4 | |a The association between parental SARS-CoV-2 infection in pregnancy and fetal growth restriction |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 07.03.2024 | ||
500 | |a Date Revised 07.03.2024 | ||
500 | |a published: Electronic-Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2023 Walter de Gruyter GmbH, Berlin/Boston. | ||
520 | |a OBJECTIVES: Although the relationship between maternal viral infections and fetal growth restriction (FGR) is well established, the association between SARS-CoV-2 infection in pregnancy and FGR remains unclear. We investigated the association between SARS-CoV-2 infection in pregnancy and FGR at a single county hospital | ||
520 | |a METHODS: We performed a prospective cohort study with cohorts matched by gestational age and month of SARS-CoV-2 PCR testing between April 2020 and July 2022. Individuals were included if they had a SARS-CoV-2 PCR testing up to 32 weeks of gestation and had a third trimester ultrasound. Primary outcome was a diagnosis of FGR, while secondary outcomes were rates of preeclampsia, small for gestational age (SGA) and birthweight. Univariate analyses, chi-square test and logistic regression were used for analysis | ||
520 | |a RESULTS: Our cohorts constituted of 102 pregnant individuals with a positive SARS-CoV-2 PCR test result and 103 pregnant individuals with a negative SARS-CoV-2 PCR test result in pregnancy. FGR rates were 17.8 % and 19.42 % among positive and negative SARS-CoV-2 cohorts respectively. While a statistical difference in preeclampsia rates was noted (34.31 % vs. 21.36 %, p=0.038) between cohorts, odds of getting preeclampsia based on SARS-CoV-2 test result was not significant (aOR 1.01, CI=0.97-1.01, p=0.75). No statistical difference was noted in demographics, FGR and SGA rates, and birthweight | ||
520 | |a CONCLUSIONS: Our findings suggest no association between SARS-CoV-2 infection in pregnancy and FGR at a single institution. Our results validate emerging data that additional fetal growth ultrasonographic assessment is not indicated solely based on SARS-CoV-2 infection status | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a birthweight | |
650 | 4 | |a fetal growth restriction | |
650 | 4 | |a maternal SARS-CoV-2 infection | |
650 | 4 | |a pregnancy | |
650 | 4 | |a small for gestational age | |
700 | 1 | |a Holt, Lauren |e verfasserin |4 aut | |
700 | 1 | |a Chandrasekaran, Suchitra |e verfasserin |4 aut | |
700 | 1 | |a Dude, Carolynn |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Journal of perinatal medicine |d 1973 |g 52(2024), 3 vom: 25. März, Seite 317-321 |w (DE-627)NLM00000636X |x 1619-3997 |7 nnns |
773 | 1 | 8 | |g volume:52 |g year:2024 |g number:3 |g day:25 |g month:03 |g pages:317-321 |
856 | 4 | 0 | |u http://dx.doi.org/10.1515/jpm-2023-0406 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 52 |j 2024 |e 3 |b 25 |c 03 |h 317-321 |